No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
COV Cleo Diagnostics Ltd
- 0.365
- +0.005+1.39%
20min DelayNot Open Dec 20 16:00 AET
46.90MMarket Cap-11.41P/E (Static)
0.365High0.355Low16.47KVolume0.360Open0.360Pre Close5.95KTurnover0.48052wk High0.02%Turnover Ratio128.50MShares0.14052wk Low-0.032EPS TTM26.65MFloat Cap0.480Historical HighLossP/E (Static)73.01MShs Float0.140Historical Low-0.032EPS LYR2.78%Amplitude--Dividend TTM5.00P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Cleo Adds Royal Women's Hospital to Its Clinical Trial for Ovarian Cancer Diagnosis
We Think Cleo Diagnostics (ASX:COV) Can Afford To Drive Business Growth
Cleo Diagnostics Ltd: ASX Listing Rule 4.10.19
Cleo Diagnostics Ltd: Appendix 4E and 2024 Annual Report
Cleo Diagnostics Identifies Trial Sites for Upcoming Blood Test Study; Shares Rise 3%
Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test
Trending AU Stocks
ASX High Dividend ASX High Dividend